Novotech Recognized as Asia Pacific Growth Leader by Frost & Sullivan Research Analysts

In recognising Novotech for the prestigious award, Frost & Sullivan’s Asia Pacific Healthcare Practice Industry Manager Sanjeev Kumarsaid “Novotech was recognised as a top CRO in Australia and Asia Pacific for excellence in service provision to biopharma clients. The company has exhibited strong growth in a complex environment and now has a physical presence in 11 Asia Pacific countries. It continues to invest in cutting-edge technology, in order to provide a high quality integrated service to its clients… Novotech’s unique focus as an Asia Pacific headquartered midsize CRO ideally complements the growing needs of the biotech community.”